Executive Summary
Across 66 overnight SEC 8-K filings from Feb 8-9, 2026, dominant themes include a heavy wave of earnings-related disclosures (25+ companies via Item 2.02/9.01, e.g., Loews, CNA Financial, Cleveland-Cliffs, Dynatrace), leadership transitions (15+ via Item 5.02, e.g., NXP Semiconductors, Phoenix Motor, Verizon), and material agreements/deals (8+ via Item 1.01, e.g., ProCap Financial, AMC Entertainment, Nauticus Robotics). All filings exhibit neutral sentiment with no disclosed quantitative enriched data such as YoY/QoQ trends, revenue figures, margins, insider trades, capital allocation, or forward-looking guidance, limiting direct metric comparisons but highlighting opacity as a portfolio risk. High materiality (7-9/10) clusters around earnings (e.g., Loews 8/10) and deals (e.g., AMC 9/10), signaling pre-market catalysts; officer changes average low materiality (3-5/10) but recur across sectors. No clear growth/margin trends identifiable due to absent period comparisons, but cross-sector earnings volume suggests early 2026 reporting season kickoff with potential volatility. Key implication: Actionable intelligence centers on reviewing exhibits/press releases for hidden metrics, as summaries flag events without numbers; watch financials (7 filings) and tech/health (multiple) for relative outperformance post-details.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from February 05, 2026.
Investment Signals(12)
- ProCap Financialβ(BULLISH)β²
Completed acquisition (Item 2.01) + material agreement (Item 1.01), high materiality 8/10 signals strategic expansion potential despite no deal terms
- Functional Brands Inc.β(BULLISH)β²
Entry into material definitive agreement (Item 1.01), materiality 8/10 with multi-item filing suggests growth catalyst
- La Rosa Holdings Corp.β(BULLISH)β²
Material definitive agreement (Item 1.01), file size 4MB indicates substantial exhibits, materiality 8/10
- Nature's Miracle Holding Inc.β(BULLISH)β²
Material agreement (Item 1.01) + potential officer refresh (Item 5.02), noted opportunities in strategic benefits
- Advantage Solutions Inc.β(BULLISH)β²
Material definitive agreement (Item 1.01) + Reg FD (Item 7.01), materiality 8/10 for possible partnership upside
- AMC Entertainmentβ(BULLISH)β²
Material definitive agreement (Item 1.01), highest materiality 9/10 in entertainment sector turnaround potential
- SHF Holdingsβ(BULLISH)β²
Material agreement (Item 1.01) + Reg FD, materiality 8/10 flags execution opportunity
- Nauticus Roboticsβ(BULLISH)β²
Multi-event filing incl. material agreement (Item 1.01), direct financial obligation (2.03), potential funding noted as opportunity
- Dynatraceβ(BULLISH)β²
Earnings release (Item 2.02) + other events (8.01), materiality 8/10 in tech monitoring space
- Cleveland-Cliffs Inc.β(BULLISH)β²
Earnings (Item 2.02), materiality 8/10 steel sector leader pre-market
- Athene Holding Ltd.β(BULLISH)β²
Earnings disclosure (Item 2.02), materiality 8/10 reinsurance strength
- Becton Dickinsonβ(BULLISH)β²
Earnings (Item 2.02), materiality 8/10 medtech staple
Risk Flags(10)
- NXP Semiconductorsβ[MEDIUM RISK]βΌ
Officer change (Item 5.02), undisclosed details signal potential issues, risk low but materiality 4/10
- ProCap Financialβ[HIGH RISK]βΌ
Unknown acquisition target/deal size + equity issuance dilution (Item 3.02), medium risk
- Phoenix Motor Inc.β[MEDIUM RISK]βΌ
Officer change undisclosed position/reasons, medium risk governance instability
- Nature's Miracleβ[HIGH RISK]βΌ
Unregistered equity sales dilution (Item 3.02) + officer uncertainty (5.02), medium risk
- Kyndryl Holdingsβ[MEDIUM RISK]βΌ
Officer change (Item 5.02) critical details missing, repeated filing flags pattern
- Advantage Solutionsβ[HIGH RISK]βΌ
Undisclosed material agreement terms, potential unfavorable conditions, medium risk
- Predictive Oncologyβ[MEDIUM RISK]βΌ
Officer change + Reg FD, undisclosed action (appointment/resignation), medium risk
- Nauticus Roboticsβ[HIGH RISK]βΌ
Equity sales (3.02) + financial obligations (2.03) + governance changes (3.03/5.03), dilution/debt risks
- IN8BIOβ[MEDIUM RISK]βΌ
Officer change undisclosed nature, medium risk instability signal
- Expand Energyβ[MEDIUM RISK]βΌ
Officer change + other events, unknown details limit governance assessment, medium risk
Opportunities(10)
- ProCap Financial/Acquisitionβ(OPPORTUNITY)β
Item 2.01 completion + Item 1.01 agreement, high materiality 8/10 for integration alpha if synergies emerge
- La Rosa Holdings/Material Agreementβ(OPPORTUNITY)β
Timely Item 1.01 filing (event date), 4MB exhibits suggest detailed upside, materiality 8/10
- AMC Entertainment/Dealβ(OPPORTUNITY)β
Item 1.01 material agreement, 9/10 materiality in recovering entertainment, pre-market mover
- SHF Holdings/Strategic Dealβ(OPPORTUNITY)β
Item 1.01 + Reg FD combo, 8/10 materiality for financing/partner alpha
- Nauticus Robotics/Funding Eventsβ(OPPORTUNITY)β
Multi-items incl. 1.01/2.03 noted as potential strategic partnership, 8/10 materiality
- Nature's Miracle/Agreementβ(OPPORTUNITY)β
Item 1.01 strategic benefits flagged, offset equity risks if accretive
- Functional Brands/Agreementsβ(OPPORTUNITY)β
Item 1.01 high materiality 8/10, consumer brands expansion play
- Advantage Solutions/Partnershipβ(OPPORTUNITY)β
Item 1.01 material deal, marketing services turnaround potential
- Dynatrace/Earningsβ(OPPORTUNITY)β
Item 2.02 in software observability, 8/10 materiality for growth check
- Cleveland-Cliffs/Resultsβ(OPPORTUNITY)β
Steel earnings Item 2.02, 8/10 materiality amid infrastructure tailwinds
Sector Themes(6)
- Earnings Wave Across Sectorsβ
25+ filings with Item 2.02 (e.g., financials like Loews/CNA/Athene 7-8/10 materiality, industrials Cleveland-Cliffs 8/10, tech Dynatrace 8/10), signals 2026 season start; no YoY data but volume implies broad check on growth/margins pre-open volatility
- Leadership Churn in Tech/Energy/Biotechβ
15+ Item 5.02 (NXP semiconductors, Phoenix Motor EV, Anavex/Ocugen biotech, EQT energy), avg materiality 3-5/10, neutral but pattern of undisclosed changes flags governance watch across growth sectors
- Deal Activity in Small-Capsβ
8 Item 1.01 filings (ProCap, LaRosa, AMC 9/10, Nauticus), medium risk dilution but high materiality 8-9/10 suggests M&A pickup for alpha in micro-caps despite opacity
- Financial Sector Disclosuresβ
7+ earnings/Reg FD (Loews 8/10, CNA 7/10, Keycorp, Park National), neutral sentiment but cluster implies sector health check, no NIM/debt trends disclosed
- Health/Medtech Earnings Clusterβ
6+ (Becton Dickinson 8/10, Waters 8/10, Labcorp, Ascend Wellness), high materiality without metrics points to pipeline/volume opportunities
- Opacity in Summariesβ
66/66 filings note 'NOT_DISCLOSED' quant data, recurring risk factor limits assessment but highlights need for exhibit dives across all
Watch List(8)
Item 2.02 high materiality 8/10, monitor pre-market for YoY revenue/margins post-exhibits Feb 9
Item 1.01 materiality 9/10, watch deal terms/exhibits for entertainment recovery catalysts Feb 9
Items 1.01/2.03/3.02 dilution risks, monitor financing impacts Feb 9
Tech earnings Item 2.02 materiality 8/10, watch guidance if released Feb 9
Steel Item 2.02 8/10, monitor volumes/costs amid tariffs Feb 9
Item 5.02 semiconductor leadership shift, watch for details/reasons Feb 9
Repeated Item 5.02 + earnings, monitor IT services stability Feb 9
Item 7.01 voluntary disclosure, watch ride-sharing metrics Feb 9
Filing Analyses(66)
09-02-2026
NXP Semiconductors N.V. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.
09-02-2026
Aeries Technology, Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001829126-26-001093, Size: 430 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results, but critical details from the exhibits are not available.
09-02-2026
Loews Corp filed an 8-K on February 9, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but specific revenue, earnings, balance sheet changes, or period-over-period comparisons are NOT_DISCLOSED. No positive or negative metrics, guidance, or scheduled events are detailed in the provided filing information.
09-02-2026
ProCap Financial, Inc. filed an 8-K on 2026-02-09 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 3.02 unregistered sales of equity securities, Item 5.02 departure/election of directors or appointment of officers including compensatory arrangements, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative financial terms, parties involved, synergies, or performance metrics were detailed.
09-02-2026
Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 09, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.
09-02-2026
BioAtla, Inc. filed a Form 8-K on February 9, 2026, under Item 8.01 reporting Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or scheduled events mentioned.
09-02-2026
Functional Brands Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001213900-26-013392, Size: 221 KB), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, transaction values, financial metrics, positive or negative impacts, or named entities are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative data available.
09-02-2026
The company filed an 8-K on February 9, 2026 (AccNo: 0001851048-26-000002), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the officer's name, title, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
09-02-2026
Broadridge Financial Solutions, Inc. filed a Form 8-K on February 9, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are explicitly stated in the filing summary. The disclosure appears informational with attached exhibits of 8 MB size.
09-02-2026
La Rosa Holdings Corp. filed a Form 8-K on 2026-02-09 reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits (file size 4 MB). This is a multi-item filing with both mandatory (Item 1.01) and voluntary (Item 8.01) disclosures, filed on the event date suggesting timely compliance within the 4-business-day requirement. No specific details on the agreement, events, transaction value, financial impacts, or exhibits are disclosed in the provided information.
09-02-2026
Nature's Miracle Holding Inc. filed a Form 8-K on 2026-02-09 disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), with financial statements and exhibits under Item 9.01. No quantitative financial impacts, transaction values, or specific details on the agreement, equity sales, or personnel changes are disclosed. This multi-item filing signals potential strategic shifts but lacks data to assess positive or negative effects.
09-02-2026
PHOENIX MOTOR INC. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names of individuals, key positions affected (e.g., CEO, CFO), reasons for the change, timing, internal/external status, or any quantitative data are disclosed. Sector is not specified.
- Β·Event date: February 09, 2026
- Β·Filing AccNo: 0001493152-26-005679
- Β·File size: 197 KB
09-02-2026
CNA Financial Corp filed an 8-K on 2026-02-09 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing reporting financial results with no specific revenue, earnings, or other metrics provided. No positive or negative performance details, period-over-period comparisons, or guidance are disclosed.
09-02-2026
Cleveland-Cliffs Inc. filed an 8-K on February 9, 2026 (AccNo: 0000764065-26-000022), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are available.
09-02-2026
Athene Holding Ltd. filed an 8-K on 2026-02-09 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This represents a standard earnings-related disclosure without detailed performance data.
09-02-2026
Curbline Properties Corp. filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-041881), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, quantitative data, period-over-period comparisons, guidance, or other numerical details are disclosed in the provided filing information. This appears to be a voluntary earnings-related disclosure with attached financial statements.
09-02-2026
EDGEWELL PERSONAL CARE Co filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), submission of matters to a vote of security holders (Item 5.07), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on the officer involved, position affected, reason for change, timing, or any quantitative financial metrics are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or governance implications are mentioned.
09-02-2026
Dynatrace, Inc. filed an 8-K on 2026-02-09 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive, negative, or flat performance data available for analysis.
09-02-2026
Apollo Global Management, Inc. filed an 8-K on February 9, 2026 (AccNo: 0001858681-26-000007), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.
09-02-2026
Becton Dickinson & Co filed an 8-K on February 9, 2026 (AccNo: 0001628280-26-006182), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.
09-02-2026
EQT Corp filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including names, titles, reasons for change, or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
09-02-2026
Sally Beauty Holdings, Inc. filed a Form 8-K on 2026-02-09 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. Specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED.
09-02-2026
Pagaya Technologies Ltd. filed an 8-K on February 9, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or performance comparisons are disclosed in the filing summary. This appears to be a standard earnings-related disclosure without detailed quantitative data provided.
09-02-2026
Kyndryl Holdings, Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on the affected position, individual name, appointment or resignation status, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
09-02-2026
Hain Celestial Group Inc filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-041905), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure of financial results with no specific revenue, earnings, guidance, or performance metrics provided in the filing summary. No positive, negative, or flat metrics are disclosed.
09-02-2026
Advantage Solutions Inc. filed a Form 8-K on February 9, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This multi-item filing includes both mandatory (Item 1.01) and voluntary (Item 7.01) disclosures, but specific details on the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or performance comparisons are provided.
09-02-2026
FIRST BANCORP /PR/ filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons, or timing were disclosed.
09-02-2026
Outdoor Holding Co filed an 8-K on 2026-02-09 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified metrics available.
09-02-2026
Lifeward Ltd. filed a Form 8-K on February 9, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transactions, or metrics are disclosed in the provided filing information. Sector is not specified.
09-02-2026
Waters Corp (/DE/) filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-041897, Size: 464 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics were explicitly stated in the filing description provided. This appears to be a standard earnings-related disclosure.
09-02-2026
Western Digital Corp filed a Form 8-K on February 9, 2026, under Item 8.01 Other Events. No specific details, financial metrics, transactions, or impacts are disclosed in the provided filing information.
09-02-2026
Kyndryl Holdings, Inc. filed a Form 8-K on February 9, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing details. This constitutes a standard earnings-related disclosure without quantified performance data.
09-02-2026
Ouster, Inc. filed an 8-K on February 9, 2026 (AccNo: 0001193125-26-041917, Size: 201 KB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific financial metrics, transactions, or events detailed in the filing summary. No quantitative data or period-over-period comparisons are provided.
09-02-2026
Powerfleet, Inc. filed an 8-K on February 9, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, period-over-period comparisons, or balance sheet effects are mentioned.
09-02-2026
Performance Food Group Co filed an 8-K on February 9, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no quantitative data or directional implications provided.
09-02-2026
Inotiv, Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001628280-26-006192, Size: 380 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results with no specific revenue, earnings, guidance, or period-over-period metrics detailed in the provided filing information. No positive, negative, or flat performance indicators were disclosed.
- Β·Sector: not specified
- Β·Source: us_sec
- Β·Event Type: Financial Results
09-02-2026
Motorcar Parts of America Inc filed an 8-K on February 9, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or guidance details are provided in the filing summary. This is a standard earnings-related disclosure with no quantified positive or negative impacts mentioned.
09-02-2026
Ocugen, Inc. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
09-02-2026
Jerash Holdings (US), Inc. filed an 8-K on February 9, 2026 (AccNo: 0001213900-26-013466), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure of financial results, but specific revenue, earnings, balance sheet changes, period-over-period comparisons, or guidance are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or transaction details were provided in the filing description.
09-02-2026
09-02-2026
FLYEXCLUSIVE INC. filed a Form 8-K on 2026-02-09 under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantitative metrics available.
09-02-2026
Anixa Biosciences Inc filed an 8-K on February 9, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving voluntary disclosure of material information to comply with Regulation FD, with attached exhibits. No specific financial metrics, transaction details, or operational data are disclosed in the provided filing information.
09-02-2026
Predictive Oncology Inc. filed an 8-K on 2026-02-09 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any governance implications are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.
09-02-2026
KEYCORP filed an 8-K on 2026-02-09 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. This appears to be a voluntary disclosure of information and exhibits without quantified impacts.
09-02-2026
Verizon Communications Inc filed an 8-K on 2026-02-09 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
09-02-2026
SurgePays, Inc. filed a Form 8-K on February 9, 2026 (AccNo: 0001493152-26-005701, size: 227 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, positive or negative changes, or other quantitative details are explicitly stated in the filing information provided. This is a single-item voluntary disclosure with no core event details, impacts, or scheduled events disclosed.
09-02-2026
Churchill Capital Corp IX/Cayman filed an 8-K on February 9, 2026, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transactions, financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing summary. Analysis is constrained by absence of detailed content.
09-02-2026
Uber Technologies, Inc. filed an 8-K on February 9, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, which attaches relevant documents. No specific details on the content of the disclosure, financial metrics, transactions, or exhibits are provided in the filing summary. No quantitative data, period-over-period comparisons, or material events with numbers are disclosed.
09-02-2026
Strategy Inc filed a Form 8-K on February 9, 2026 (AccNo: 0001193125-26-041944, Size: 341 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). This is a multi-item voluntary disclosure with no specific details on events, transactions, financial metrics, or performance provided. No quantitative data, positive or negative developments, growth, declines, or flat metrics were mentioned.
09-02-2026
PARK NATIONAL CORP /OH/ filed an 8-K on 2026-02-09 (AccNo: 0000805676-26-000012, Size: 8 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing focused on voluntary disclosure compliance.
09-02-2026
09-02-2026
Transocean Ltd. filed a Form 8-K on February 9, 2026 (AccNo: 0001104659-26-011776), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other event, financial statements, exhibits, transaction values, metrics, or impacts are disclosed. No positive, negative, or flat performance metrics are mentioned.
09-02-2026
Universal Corp /VA/ filed an 8-K on February 9, 2026 (AccNo: 0001628280-26-006200), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, title, reason, or timing, are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned.
09-02-2026
Ascend Wellness Holdings, Inc. filed an 8-K on February 9, 2026, disclosing Results of Operations and Financial Condition under Item 2.02 along with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data.
09-02-2026
PulteGroup Inc/MI/ filed an 8-K on 2026-02-09 under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons, effective dates, or quantitative details were disclosed in the provided filing summary.
09-02-2026
News Corp filed an 8-K on February 9, 2026, disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific details on the nature of the other events, financial metrics, transactions, or impacts are provided in the filing summary. No quantitative data, period-over-period comparisons, or directional metrics (positive, negative, or flat) are mentioned.
09-02-2026
EXPAND ENERGY Corp filed an 8-K on 2026-02-09 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details such as the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data like compensation amounts are disclosed. This appears to be a routine disclosure of leadership transition without further context provided.
09-02-2026
AMC Entertainment Holdings, Inc. filed a Form 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction values, financial impacts, or quantitative metrics were provided in the filing summary. This is a multi-item informational filing with no disclosed positive or negative metrics.
09-02-2026
SHF Holdings, Inc. filed an 8-K on February 9, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons are provided in the available information. This is a multi-item filing with no disclosed quantitative impacts.
09-02-2026
Labcorp Holdings Inc. filed an 8-K on 2026-02-09 disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the officer involved, position affected, reason for change, timing, or any quantitative data are disclosed in the provided filing summary.
09-02-2026
Ventas, Inc. filed a Form 8-K on February 9, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no quantitative data or directional implications provided.
09-02-2026
IN8BIO, INC. filed an 8-K on 2026-02-09 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are disclosed. No quantitative data, financial metrics, or other changes are mentioned.
- Β·AccNo: 0001193125-26-041975
- Β·File size: 140 KB
- Β·Event date: 2026-02-09
- Β·Sector: NOT_DISCLOSED
09-02-2026
Nauticus Robotics, Inc. filed a multi-item Form 8-K on February 9, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This filing indicates multiple significant corporate actions but lacks quantitative data for balanced assessment of positive or negative effects.
09-02-2026
Empery Digital Inc. filed a Form 8-K on February 9, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the events, transactions, financial metrics, or exhibits are provided in the filing summary. This multi-item filing provides limited informational disclosure without quantifiable impacts.
09-02-2026
Turn Therapeutics Inc. filed an 8-K on February 9, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information. All further details such as impacts, guidance, or events are NOT_DISCLOSED.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 66 filings
πΊπΈ More from United States
View all βMarch 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings β March 24, 2026
US Corporate Distress Financial Stress SEC Filings